Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 151-157

  Endo, Satoshi ^a,b   Matsunaga, Toshiyuki ^a   Mamiya, Hiroaki ^a   Hara, Akira ^a   Kitade, Yukio ^b   Tajima, Kazuo ^c   El Kabbani, Ossama ^d  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Dicarbonyl compound; 3 Deoxyglucosone; AKR1B13; Aldo keto reductase superfamily; Aldose reductase; Oxidative stress

Indexed keywords

1,2 DICARBONYL DERIVATIVE; 1,4 NAPHTHOQUINONE; 3 DEOXYGLUCOSONE; 4 HYDROXYNONENAL; ACROLEIN; ALCOHOL DERIVATIVE; ALDEHYDE DERIVATIVE; ALDEHYDE REDUCTASE; ALDO KETO REDUCTASE 1B13; ANDROSTANOLONE; BENZBROMARONE; ESTRADIOL; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FLAVONOID; GLYOXAL; HEXESTROL; HYDROGEN PEROXIDE; METHYLGLYOXAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; IMMUNOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; UPREGULATION;

ALDEHYDE REDUCTASE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DNA PRIMERS; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MUTAGENESIS, SITE-DIRECTED; NADP; OXIDATIVE STRESS; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUBSTRATE SPECIFICITY;

RATTUS;

EID: 59049093973     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.010     Document Type: Article

References (49)

1. Dury E.J., Hyndman D., Jin Y., and Penning T.M. In: Weiner H., Maser E., Lindahl R., and Plapp B. (Eds). Enzymology and Molecular Biology of Carbonyl Metabolism, vol. 13 (2007), Purdue University Press, West Lafayette, IN 184-197
2. Kador P.F. The role of aldose reductase in the development of diabetic complications. Med. Res. Rev. 8 (1988) 325-352
3. Oates P.J. Aldose reductase, still a compelling target for diabetic neuropathy. Curr. Drug Targets 9 (2008) 14-36
4. Wermuth B., and Monder C. Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity. Eur. J. Biochem. 131 (1983) 423-426
5. Petrash J.M. All in the family: aldose reductase and closely related aldo-keto reductases. Cell. Mol. Life Sci. 61 (2007) 737-749
6. Conklin D., Prough R., and Bhatanagar A. Aldehyde metabolism in the cardiovascular system. Mol. Biosyst. 3 (2007) 136-150
7. Hyndman D.J., and Flynn T.G. Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim. Biophys. Acta 1399 (1998) 198-202
8. Cao D., Fan S.T., and Chung S.S. Identification and characterization of a novel human aldose reductase-like gene. J. Biol. Chem. 273 (1998) 11429-11435
9. Donohue P.J., Alberts G.F., Hampton B.S., and Winkles J.A. A delayed-early gene activated by fibroblast growth factor-1 encodes a protein related to aldose reductase. J. Biol. Chem. 269 (1994) 8604-8609
10. Pailhoux E.A., Martinez A., Veyssiere G.M., and Jean C.G. Androgen-dependent protein from mouse vas deferens. cDNA cloning and protein homology with the aldo-keto reductase superfamily. J. Biol. Chem. 265 (1990) 19932-19936
11. Zeindl-Eberhart E., Klugbauer S., Dimitrijevic N., Jungblut P.R., Lamer S., and Rabes H.M. Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Electrophoresis 22 (2001) 3009-3018
12. Srivastava S., Harter T.M., Chandra A., Bhatnagar A., Srivastava S.K., and Petrash J.M. Kinetic studies of FR-1, a growth factor-inducible aldo-keto reductase. Biochemistry 37 (1998) 12909-12917
13. Lefrançois-Martinez A.M., Tournaire C., Martinez A., Berger M., Daoudal S., Tritsch D., Veyssière G., and Jean C. Product of side-chain cleavage of cholesterol, isocaproaldehyde, is an endogenous specific substrate of mouse vas deferens protein, an aldose reductase-like protein in adrenocortical cells. J. Biol. Chem. 274 (1999) 32875-32880
14. Martinez A., Aigueperse C., Val P., Dussault M., Tournaire C., Berger M., Veyssière G., Jean C., and Lefrançois-Martinez A. Physiological functions and hormonal regulation of mouse vas deferens protein (AKR1B7) in steroidogenic tissues. Chem. Biol. Interact. 130-132 (2001) 903-917
15. Crosas B., Hyndman D.J., Gallego O., Martras S., Parés X., Flynn T.G., and Farrés J. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem. J. 373 (2003) 973-979
16. Martin H.J., Breyer-Pfaff U., Wsol V., Venz S., Block S., and Maser E. Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. Drug Metab. Dispos. 34 (2006) 464-470
17. Lau E.T., Cao D., Lin C., Chung S.K., and Chung S.S. Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland. Biochem. J. 312 (1995) 609-615
18. Fukumoto S., Yamauchi N., Moriguchi H., Hippo Y., Watanabe A., Shibahara J., Taniguchi H., Ishikawa S., Ito H., Yamamoto S., Iwanari H., Hironaka M., Ishikawa Y., Niki T., Sohara Y., Kodama T., Nishimura M., Fukayama M., Dosaka-Akita H., and Aburatani H. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11 (2005) 1776-1785
19. Yoshitake H., Takahashi M., Ishikawa H., Nojima M., Iwanari H., Watanabe A., Aburatani H., Yoshida K., Ishi K., Takamori K., Ogawa H., Hamakubo T., Kodama T., and Araki Y. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer. Int. J. Gynecol. Cancer 17 (2007) 1300-1306
20. Endo S., Matsunaga T., Horie K., Tajima K., Bunai Y., Carbone V., El-Kabbani O., and Hara A. Enzymatic characteristics of an aldo-keto reductase family protein (AKR1C15) and its localization in rat tissues. Arch. Biochem. Biophys. 465 (2007) 136-147
21. Matsunaga T., Shintani S., and Hara A. Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokin. 21 (2006) 1-18
22. Matsuura K., Deyashiki Y., Bunai Y., Ohya I., and Hara A. Aldose reductase is a major reductase for isocaproaldehyde, a product of side-chain cleavage of cholesterol, in human and animal adrenal glands. Arch. Biochem. Biophys. 328 (1996) 265-271
23. Zagalak B., Frey P.A., Karabatsos G.L., and Abeles R.H. The stereochemistry of the conversion of D and L 1, 2-propanediols to propionaldehyde. J. Biol. Chem. 241 (1966) 3028-3035
24. Esterbauer H., and Weger W. Uber die Wirkungen von aldehyden auf gesunde und maligne Zellen, 3. Mitt: Synthese von homologen 4-hydroxy-2-alkenalen, II. Monatsh. Chem. 98 (1967) 1994-2000
25. Monder C., and Furfine C.S. 21-Hydroxysteroid dehydrogenase of liver and adrenal. Methods Enzymol. 15 (1989) 667-675
26. Tajima K., Hashizaki M., Yamamoto K., and Mizutani T. Metabolism of 3-tert-butyl-4-hydroxyanisole by horseradish peroxidase and hydrogen peroxide. Drug Metab. Dispos. 20 (1992) 816-820
27. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
28. Nakanishi M., Deyashiki Y., Ohshima K., and Hara A. Cloning, expression and tissue distribution of mouse tetrameric carbonyl reductase. Identity with an adipocyte 27-kDa protein. Eur. J. Biochem. 228 (1995) 381-387
29. Old S.E., Sato S., Kador P.F., and Carper D.A. In vitro expression of rat lens aldose reductase in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 4942-4945
30. Ishikura S., Matsumoto K., Sanai M., Horie K., Matsunaga T., Tajima K., El-Kabbani O., and Hara A. Molecular cloning of a novel type of rat cytoplasmic 17β-hydroxysteroid dehydrogenase distinct from the type 5 isozyme. J. Biochem. 139 (2006) 1053-1063
31. +-dependent 3α-hydroxysteroid dehydrogenase (AKR1C17): a member of the aldo-keto reductase family highly expressed in kidney cytosol. Arch. Biochem. Biophys. 464 (2007) 122-129
32. Parés X., and Julià P. Isoenzymes of alcohol dehydrogenase in retinoid metabolism. Methods Enzymol. 189 (1990) 436-441
33. Harlow E., and Lane D. Antibodies: A Laboratory Manual (1998), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
34. Domenighetti A.A., Beny J.L., Chabaud F., and Frieden M. An intercellular regenerative calcium wave in porcine coronary artery endothelial cells in primary culture. J. Physiol. 513 (1998) 103-116
35. Matsunaga T., Kamiya T., Sumi D., Kumagai Y., Kalyanaraman B., and Hara A. L-Xylulose reductase is involved in 9,10-phenanthrenequinone-induced apoptosis in human T-lymphoma cells. Free Rad. Biol. Med. 44 (2008) 1191-1202
36. Varma S.D., Mizuno A., and Kinoshita J.H. Diabetic cataracts and flavonoids. Science 195 (1977) 205-206
37. Klemin S., Calvo R.Y., Bond S., Dingess H., Rajkumar B., Perez R., Chow L., and Balendiran G.K. WY 14 643 inhibits human aldose reductase activity. J. Enzyme Inhib. Med. Chem. 21 (2006) 569-573
38. Verma M., Martin H.J., Haq W., O'Connor T.R., Maser E., and Balendiran G.K. Inhibiting wild-type and C299S mutant AKR1B10; a homologue of aldose reductase upregulated in cancers. Eur. J. Pharmacol. 584 (2008) 213-221
39. Higaki Y., Kamiya T., Usami N., Shintani S., Shiraishi H., Ishikura S., Yamamoto I., and Hara A. Molecular characterization of two monkey dihydrodiol dehydrogenases. Drug Metab. Pharmacokin. 17 (2002) 336-348
40. Kanazu T., Shinoda M., Nakayama T., Deyashiki Y., Hara A., and Sawada H. Aldehyde reductase is a major protein associated with 3-deoxyglucosone reductase activity in rat, pig and human livers. Biochem. J. 279 (1991) 903-906
41. Ellis E.M., and Hayes J.D. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase. Biochem. J. 312 (1995) 535-541
42. 1-aldehyde reductase. Biochem. J. 332 (1998) 21-34
43. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11 (1991) 81-128
44. Stevens J.F., and Maier C.S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52 (2008) 7-25
45. Degenhardt T.P., Brinkmann-Frye S.R., Baynes J.W., O'Brien J., and Nursten H.E. In: Crabbe M.J.C., and Ames J.M. (Eds). The Maillard Reactions in Foods and Medicine (1998), The Royal Society of Chemistry, Cambridge 3-10
46. Thornally P.L. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmac. 27 (1996) 565-573
47. Takahashi M., Fujii J., Teshima T., Suzuki K., Shiba T., and Taniguchi N. Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene 127 (1993) 249-253
48. Villablanca A.C., Lewis K.A., and Rutledge J.C. Time- and dose-dependent differential upregulation of three genes by 17β-estradiol in endothelial cells. J. Appl. Physiol. 92 (2002) 1064-1073
49. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chem. Res. Toxicol. 13 (2000) 135-160